BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29883295)

  • 1. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.
    Yan AC; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):194-199. PubMed ID: 29883295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
    Catuogno S; Esposito CL; Giangrande PH
    Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells.
    Thiel WH; Thiel KW; Flenker KS; Bair T; Dupuy AJ; McNamara JO; Miller FJ; Giangrande PH
    Methods Mol Biol; 2015; 1218():187-99. PubMed ID: 25319652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for siRNA navigation to desired cells.
    Sioud M
    Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of cell surface targeting aptamers.
    Kelly L; Maier KE; Yan A; Levy M
    Nat Commun; 2021 Nov; 12(1):6275. PubMed ID: 34725326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
    Kruspe S; Giangrande PH
    Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.
    Giudice V; Mensitieri F; Izzo V; Filippelli A; Selleri C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers as targeted therapeutics: current potential and challenges.
    Zhou J; Rossi J
    Nat Rev Drug Discov; 2017 Mar; 16(3):181-202. PubMed ID: 27807347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA aptamers: a review of recent trends and applications.
    Kang KN; Lee YS
    Adv Biochem Eng Biotechnol; 2013; 131():153-69. PubMed ID: 22491855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
    Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
    J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
    Bagalkot V; Gao X
    ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.